Trials / Completed
CompletedNCT02113423
Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Fujian Cancer Hospital · Other Government
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of the study is to address the efficacy and toxicity profile of aforementioned four modalities for rT1-2 NPC. Characters of the patients: * list item one: 168 patients, median age 48 years (range 16-75 years) proven rT1-2 NPC were diagnosed * list item two: Treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT Combined 3D-CRT or IMRT). * list item three: Median time to recurrence was 30 months (range 1-180months). The median follow-up time was 28 months (range, 4-135 months).
Detailed description
Objectives: Recurrent T1-2 Nasopharyngeal Carcinoma (rT1-2) may be salvaged by 3D - CRT(3D-Conformal Radiotherapy), IMRT( Intensity Modulated Radiotherapy), Brachytherapy (BT), BT combined 3D - CRT or IMRT . The aim of this study is to address the efficacy and toxicity profile of aforementioned four modalities for rT1-2 NPC. Methods and Materials: 168 patients, median age 48 years (range 16-75 years) proven rT1-2 NPC were diagnosed and treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT Combined 3D-CRT or IMRT) . Median time to recurrence was 30 months (range 1-180months). The median follow-up time was 28 months (range, 4-135 months).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT | 3D - CRT(3D-Conformal Radiotherapy): CTV-P 50-60Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) IMRT(Intensity Modulated Radiotherapy): GTV-P 50-60 Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) BT(Brachytherapy): 2.5Gy BID\*10F one week interval BT combined 3D - CRT or IMRT: First,GTV-P 40Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week);Then, 2.5Gy BID\*2F |
Timeline
- Start date
- 1996-01-01
- Primary completion
- 2009-06-01
- Completion
- 2011-03-01
- First posted
- 2014-04-14
- Last updated
- 2014-04-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02113423. Inclusion in this directory is not an endorsement.